Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Guggenheim

EyePoint Pharmaceuticals Inc.
Start price
€13.00
24.06.26 / 50%
Target price
€59.83
24.06.27
Performance (%)
-12.31%
Price
€11.70
10.08.26
Summary
This prediction is currently active. The prediction for EyePoint Pharmaceuticals Inc. disappoints with a performance of -12.31%. This prediction currently runs until 24.06.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
EyePoint Pharmaceuticals Inc. 12.500% 12.500%
iShares Core DAX® 0.184% 5.072%
iShares Nasdaq 100 -0.770% -2.079%
iShares Nikkei 225® 0.733% -3.346%
iShares S&P 500 -0.166% 0.904%

Comments by Guggenheim for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -12.31%
Target price 59.833
Change
Ends at 24.06.27

Eyepoint Pharmaceuticals (EYPT) had its "buy" rating reaffirmed by Guggenheim. They now have a $68.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat

Guggenheim 
0
Report Share
24.06.26